Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors in the central anxious process, conolidine modulates alternate molecular targets. A Science Innovations review located that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://conolidineisnotanopioid82355.blogpixi.com/38003617/the-ultimate-guide-to-alternative-natural-pain-relief-to-replace-traditional-painkillers